These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 21544310

  • 1. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
    Pixley RA, Espinola RG, Ghebrehiwet B, Joseph K, Kao A, Bdeir K, Cines DB, Colman RW.
    Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
    [Abstract] [Full Text] [Related]

  • 2. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells.
    Mahdi F, Shariat-Madar Z, Todd RF, Figueroa CD, Schmaier AH.
    Blood; 2001 Apr 15; 97(8):2342-50. PubMed ID: 11290596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
    Joseph K, Ghebrehiwet B, Kaplan AP.
    Clin Immunol; 1999 Sep 15; 92(3):246-55. PubMed ID: 10479529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.
    Khan MM, Bradford HN, Isordia-Salas I, Liu Y, Wu Y, Espinola RG, Ghebrehiwet B, Colman RW.
    Arterioscler Thromb Vasc Biol; 2006 Oct 15; 26(10):2260-6. PubMed ID: 16902163
    [Abstract] [Full Text] [Related]

  • 7. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP, Natesan S, Joseph K, Kaplan AP.
    Thromb Haemost; 2003 Nov 15; 90(5):787-95. PubMed ID: 14597972
    [Abstract] [Full Text] [Related]

  • 8. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.
    Mahdi F, Madar ZS, Figueroa CD, Schmaier AH.
    Blood; 2002 May 15; 99(10):3585-96. PubMed ID: 11986212
    [Abstract] [Full Text] [Related]

  • 9. Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
    Mahdi F, Shariat-Madar Z, Kuo A, Carinato M, Cines DB, Schmaier AH.
    J Biol Chem; 2004 Apr 16; 279(16):16621-8. PubMed ID: 14764580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP.
    Thromb Haemost; 2001 Jan 16; 85(1):119-24. PubMed ID: 11204562
    [Abstract] [Full Text] [Related]

  • 13. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Jan 16; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP, Ghebrehiwet B.
    Mol Immunol; 2010 Aug 16; 47(13):2161-9. PubMed ID: 20580091
    [Abstract] [Full Text] [Related]

  • 18. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
    Colman RW, Pixley RA, Najamunnisa S, Yan W, Wang J, Mazar A, McCrae KR.
    J Clin Invest; 1997 Sep 15; 100(6):1481-7. PubMed ID: 9294114
    [Abstract] [Full Text] [Related]

  • 19. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1.
    Ghebrehiwet B, Geisbrecht BV, Xu X, Savitt AG, Peerschke EIB.
    Semin Immunol; 2019 Oct 15; 45():101338. PubMed ID: 31744753
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.